Thrombophilia
   
Search  

 Go

 
 

Thrombophilia

Clinical Aspects | Genetic Causes | Acquired Causes

Genetic Causes of Venous Thrombosis

Specific genetic defects should be suspected when a thrombotic event has any of the following characteristics12,14,15:

  • Spontaneous with no predisposing condition, such as prolonged immobilization or surgery
  • Patient suffers from more than one thrombotic event
  • Patient has a positive family history of thrombosis
  • Patient is less than 50 years old
  • Thrombosis occurs at an unusual site (eg, mesenteric or cerebral brain)

Three general categories of test methodology are useful in the assessment of congenital thrombotic conditions:

  1. Genetic tests for specific mutations
  2. Clotting-based measurements for specific factor activity levels
  3. Immunoassays to measure the concentration of specific antigens

Genetic conditions associated with thrombophilia are listed below in order of their relative frequency of occurrence.12,14,16

Table 1.-Genetic Conditions Associated With Thrombosis.

Genetic Condition

Testing Method

Test Number

Methylenetetrahydrofolate

Reductase (MTHFR) Gene Mutation

Screen: Homocysteine level

Confirmation: MTHFR genetic testing

706994

511238

Factor V Leiden Mutation

Screen: Activated protein C resistance

Confirmation: Genetic testing

117762

511154

Prothrombin 20210

Genetic testing only

511162

Increased Factor VIII *

Factor VIII activity

086264

Protein S Deficiency

Screen: Protein S activity Profile: (activity, total/free antigen)

164525
117754

Protein C Deficiency

Screen: Protein C activity profile (activity and antigen)

117705
080465

Antithrombin Deficiency

Screen: Antithrombin activity profile (activity and antigen)

015040
015594

Dysfibrinogenemia

Fibrinogen activity

Fibrinogen antigen

001610
117052

*While factor VIII elevation is associated with a number of acquired conditions, some individuals appear to have congenitally elevated factor VIII levels that are associated with increased risk of thrombosis.12

Genetic testing is useful for the diagnosis or confirmation of MTHFR, factor V Leiden, and the prothrombin 20210 mutations. Regardless of clinical status, genetic testing can be definitive because the patient's DNA remains constant. Antigen and activity levels must be measured to diagnose the other congenital thrombotic conditions. It is important to understand, however, that the results of activity and antigen level tests can be affected by the clinical state of the patient. In many clinical circumstances, such as those listed below, tests for activity or antigen levels may produce misleading results if the clinical state of the patient is not considered.14,16

Table 2.-Clinical Conditions that Affect Tests for Congenital Thrombotic Risk.

Clinical Condition Effect
Heparin therapy or contamination Decreases antithrombin
Warfarin therapy/vitamin K deficiency Decreases protein C and protein S
Recent thrombosis or surgery Decreases antithrombin, protein C, protein S
Increases homocysteine
DIC, liver disease, sepsis, L-asparaginase therapy Decreases antithrombin, protein C, protein S
Kidney disease/nephrotic syndrome Decreases antithrombin and protein S
Acute phase reaction, inflammation, infection
Increases factor VIII
Decreases protein S
Pregnancy or postpartum period Decreases protein S and APCR
Increases homocysteine
Oral contraceptives or estrogen replacement Decreases antithrombin and protein S
Lupus anticoagulants (LA) Decreases APCR, protein S, and factor VIII

Vitamin B12, folate, or B6 deficiency
Treatment with methotrexate, phenytoin, or theophylline Hypothyroidism, malignancy, menopause

Increases homocysteine

References

 

Home | About LabCorp | Centers of Excellence | Services | Connectivity Solutions | Site Map

For questions or comments about this site, please contact the LabCorp Webmaster.
Privacy Statement
©2007 Laboratory Corporation of America® Holdings
All Rights Reserved